CD40 and colitis: In 2015, a study by Song et al. addressed the contribution of ILC and T cells to anti-CD40-mediated colitis, making effective use of engineered mice harboring severely reduced numbers of NKp46+ ILC3, all ILC3, T cells or both ILC3 and T cells.